Regeneron Pharmaceuticals (Ondo Tokenized) Price

Regeneron Pharmaceuticals Tokenized Stock (Ondo) (REGNon) is a cryptocurrency. It falls squarely within the Real World Assets (RWA) category, minting on-chain exposure to Regeneron Pharmaceuticals equity. Ondo Finance engineered this token as part of its Global Markets ecosystem.

The asset functions as a boundary-agnostic conduit into the performance of a U.S. biopharma giant. Non-U.S. participants, both retail and institutional, circumvent fragmented broker-dealer networks and time-zone gaps. The token’s core innovation collapses the settlement latency and custodial frictions that typically wall off American securities from international capital. Minting and redemption operate continuously, five days a week.

REGNon operates on the Solana, Ethereum, and BNB Smart Chain networks. These distinct execution environments ensure broad composability and redundancy. No single chain anchors the token’s finality.

On Solana, the token adheres to the SPL standard, while the Ethereum instance implements ERC-20. The BNB Smart Chain deployment follows the BEP-20 specification. This multichain footprint grants developers the ability to integrate REGNon into a wide array of DeFi protocols without bridging fragility.

Ondo Finance launched its tokenized securities initiative to bridge traditional markets with decentralized infrastructure. The Regeneron token materialized as part of this product line. No discrete founder is ascribed to the asset; rather, the Ondo protocol team collectively architected the smart contract infrastructure. Early adoption traces back to the platform’s broader tokenized stock rollout.

The overarching objective is to dismantle geographic and temporal barriers that inhibit global access to premier equities. By programmatically wrapping a mature stock into a cryptographic bearer asset, Ondo shifts the locus of market access from centralized exchange memberships to permissionless wallets. This reorientation intends to broaden the investable universe for capital stranded in jurisdictions with limited brokerage choices.

Mechanically, REGNon captures the economic rights of the underlying Regeneron common stock, with dividends systematically reinvested into the token’s net asset value. The mint-and-redeem mechanism ties each token to a custody reserve of actual shares held by a regulated entity. No governance votes or staking yields attach to the token—it is a pure exposure instrument.

A Chilean retail investor acquires REGNon to replicate the stock’s return profile without opening a U.S. brokerage account during Eastern Time night hours. A global macro fund employs the token to hedge biotech exposure while maintaining portfolio liquidity, redeeming back to the underlying shares when traditional exchanges reopen. Arbitrageurs monitor the token’s premium or discount to the NYSE price for cross-market opportunities.

REGNon has a total supply of 0.368293 tokens. Currently, 0.368293 tokens are in circulation. With a market capitalization of $274.43, Regeneron Pharmaceuticals Tokenized Stock (Ondo) ranks #12,366 among all cryptocurrencies.